Utilizing specific antagonists and knockout studies, it was demonstrated that ANP and BNP played a counter-regulatory role against the fibrosis intracardiac RAAS and may eventually prevent cardiac hypertrophy [27]. The gene discussed is NPPB; the disease is cardiac hypertrophy.